Sign In
Buy PIII
$10.05
-2.74 (-21.42%)
At Close: Jun 03, 2026
P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement
08:00am, Thursday, 23'rd May 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (Nasdaq: PIII), a patient- centered and physician-led population health management company (the “Company”), today announced that it has en
P3 Health Partners Inc. (PIII) Q1 2024 Earnings Call Transcript
06:05am, Saturday, 11'th May 2024
P3 Health Partners Inc. (NASDAQ:PIII ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Ryan Halsted - Gilmartin Group Sherif Abdou - Strategic Advisor Atul Kavthekar - CFO
P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:26pm, Thursday, 09'th May 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), today reported that the Board of Directors (the “Board”) (including the independent member
P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call
08:00am, Thursday, 02'nd May 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans t
P3 Health Partners Inc. (PIII) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
11:05am, Wednesday, 01'st May 2024
P3 Health Partners (PIII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference
08:00am, Wednesday, 03'rd Apr 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is sched
P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript
10:04pm, Thursday, 28'th Mar 2024
P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript
P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results
04:05pm, Thursday, 28'th Mar 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
08:00am, Friday, 15'th Mar 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the
P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum
08:00am, Thursday, 07'th Mar 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced tha
P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit
08:00am, Wednesday, 28'th Feb 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced management will particip
P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference
08:00am, Monday, 19'th Feb 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is sched
P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
08:00am, Tuesday, 30'th Jan 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate
P3 Health Partners stock pops on bullish 2024 revenue guidance
05:47am, Wednesday, 10'th Jan 2024
P3 Health Partners shares jumped in Wednesday premarket trading after the healthcare company guided for a strong rise in 2024 revenue and positive underlying earnings (EBITDA) as it grows its Medicare
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024
07:29pm, Tuesday, 09'th Jan 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, is participating in
